Main outcome measures included inflammatory and endothelial biomarkers (IL-6, IL-8, angiopoietin-2, syndecan-1), body fluid composition assessed by bioelectrical impedance, and clinical outcomes, including acute kidney injury (AKI), ICU length of stay (LOS), and ICU mortality. This evidence concerns the gene SDC1 and acute kidney injury.